everolimus 2 MG Tablet for Oral Suspension

RxCUI: 1308428
RxNorm name: everolimus 2 MG Tablet for Oral Suspension
Display name: everolimus 2 MG Tablet for Oral Suspension
Full name: everolimus 2 MG Tablet for Oral Suspension
Term type: SCD
Status: DailyMed mapping
Updated: 2026-06-04 23:38:50

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 4 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Everolimus	EVEROLIMUS	Biocon Pharma Inc.	5b809dfe-c076-07c5-207e-178c3f0d32d3	2026-06-30	Warnings, Adverse reactions	Exact identifier rxcui: 1308428
EVEROLIMUS	EVEROLIMUS	Amneal Pharmaceuticals NY LLC	6f1ae129-c21e-4c25-84c1-a6757d9a7eb2	2026-06-16	Warnings, Adverse reactions	Exact identifier rxcui: 1308428
Afinitor	EVEROLIMUS	Novartis Pharmaceuticals Corporation	2150f73a-179b-4afc-b8ce-67c85cc72f04	2026-06-01	Warnings, Adverse reactions	Exact identifier rxcui: 1308428
Everolimus	EVEROLIMUS	Breckenridge Pharmaceutical, Inc.	01f7b5fb-be0d-4adf-acd2-6899018de966	2025-09-05	Warnings, Adverse reactions	Exact identifier rxcui: 1308428

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 4 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
2150f73a-179b-4afc-b8ce-67c85cc72f04	everolimus 2 MG Tablet for Oral Suspension [PSN] · everolimus 2 MG Tablet for Oral Suspension [SCD]	2	66	These highlights do not include all the information needed to use AFINITOR/AFINITOR DISPERZ safely and effectively. See full prescribing information for AFINITOR/AFINITOR DISPERZ. AFINITOR ® (everolimus) tablets, for oral use AFINITOR DISPERZ ® (everolimus tablets for oral suspension) Initial U.S. Approval: 2009	20260212
01f7b5fb-be0d-4adf-acd2-6899018de966	everolimus 2 MG Tablet for Oral Suspension [PSN] · everolimus 2 MG Tablet for Oral Suspension [SCD]	2	20	These highlights do not include all the information needed to use EVEROLIMUS TABLETS/EVEROLIMUS TABLETS FOR ORAL SUSPENSION safely and effectively. See full prescribing information for EVEROLIMUS TABLETS/EVEROLIMUS TABLETS FOR ORAL SUSPENSION. EVEROLIMUS tablets, for oral use EVEROLIMUS tablets for oral suspension Initial U.S. Approval: 2009	20250905
5b809dfe-c076-07c5-207e-178c3f0d32d3	everolimus 2 MG Tablet for Oral Suspension [PSN] · everolimus 2 MG Tablet for Oral Suspension [SCD]	2	5	These highlights do not include all the information needed to use EVEROLIMUS TABLETS FOR ORAL SUSPENSION safely and effectively. See full prescribing information for EVEROLIMUS TABLETS FOR ORAL SUSPENSION . EVEROLIMUS tablets for oral suspension Initial U.S. Approval: 2009	20260114
6f1ae129-c21e-4c25-84c1-a6757d9a7eb2	everolimus 2 MG Tablet for Oral Suspension [PSN] · everolimus 2 MG Tablet for Oral Suspension [SCD]	2	4	These highlights do not include all the information needed to use EVEROLIMUS TABLETS FOR ORAL SUSPENSION safely and effectively. See full prescribing information for EVEROLIMUS TABLETS FOR ORAL SUSPENSION . EVEROLIMUS tablets for oral suspension Initial U.S. Approval: 2009	20260409